Zivo Bioscience Inc logo

ZIVO - Zivo Bioscience Inc Share Price

$0.147 -0.0  -1.3%

Last Trade - 23/10/20

Consumer Defensives
Micro Cap
Market Cap £45.9m
Enterprise Value £49.9m
Revenue £15.3k
Position in Universe 4721st / 6447
Unlock ZIVO Revenue
Relative Strength (%)
1m +23.5%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -16.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 June 2020, Zivo Bioscience Inc revenues increased from $0K to $20K. Net loss decreased 34% to $3.7M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Interest expense related parties decrease of 90% to $225K (expense), Professional fees and Consulting Expense decrease of 63% to $375K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


ZIVO Revenue Unlock ZIVO Revenue

Net Income

ZIVO Net Income Unlock ZIVO Revenue

Normalised EPS

ZIVO Normalised EPS Unlock ZIVO Revenue

PE Ratio Range

ZIVO PE Ratio Range Unlock ZIVO Revenue

Dividend Yield Range

ZIVO Dividend Yield Range Unlock ZIVO Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ZIVO EPS Forecasts Unlock ZIVO Revenue
Profile Summary

Zivo Bioscience, Inc., formerly Health Enhancement Products, Inc., is a biotechnology company. The Company is engaged in the study, development and commercialization of naturally derived compounds and bioactive molecules created by algal and bacterial hosts. The Company focuses on research and identification of its bioactive ingredients. It focuses to sell natural bioactive ingredients derived from its algae cultures to animal, human and dietary supplement and medical food manufacturers. It is also engaged in development of biologically derived and synthetic candidates for medicinal and pharmaceutical applications in humans and animals, specifically focused on autoimmune and inflammatory response modulation. It focuses on developing, manufacturing, marketing and selling tests that allow users to optimize personal health and identify future health risks. The Company manufactures algal products and derivatives, and has various product platforms.

Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated March 28, 1983
Public Since October 6, 2000
No. of Shareholders: 212
No. of Employees: 5
Sector Consumer Defensives
Industry Food & Tobacco
Exchange Pink Sheets on Nasdaq
Shares in Issue 406,914,909
Free Float (0.0%)
Eligible for
ZIVO Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for ZIVO
Upcoming Events for ZIVO
Frequently Asked Questions for Zivo Bioscience Inc
What is the Zivo Bioscience Inc share price?

As of 23/10/20, shares in Zivo Bioscience Inc are trading at $0.147, giving the company a market capitalisation of £45.9m. This share price information is delayed by 15 minutes.

How has the Zivo Bioscience Inc share price performed this year?

Shares in Zivo Bioscience Inc are currently trading at $0.147 and the price has moved by 0.120k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Zivo Bioscience Inc price has moved by 0.103k% over the past year.

What are the analyst and broker recommendations for Zivo Bioscience Inc?

There are no analysts currently covering Zivo Bioscience Inc.

When will Zivo Bioscience Inc next release its financial results?

Zivo Bioscience Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Zivo Bioscience Inc dividend yield?

Zivo Bioscience Inc does not currently pay a dividend.

Does Zivo Bioscience Inc pay a dividend?

Zivo Bioscience Inc does not currently pay a dividend.

When does Zivo Bioscience Inc next pay dividends?

Zivo Bioscience Inc does not currently pay a dividend.

How do I buy Zivo Bioscience Inc shares?

To buy shares in Zivo Bioscience Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Zivo Bioscience Inc?

Shares in Zivo Bioscience Inc are currently trading at $0.147, giving the company a market capitalisation of £45.9m.

Where are Zivo Bioscience Inc shares listed? Where are Zivo Bioscience Inc shares listed?

Here are the trading details for Zivo Bioscience Inc:

Country of listing: United States
Exchange: PNK
Ticker Symbol: ZIVO
What kind of share is Zivo Bioscience Inc?

Based on an overall assessment of its quality, value and momentum, Zivo Bioscience Inc is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Zivo Bioscience Inc share price forecast 2020?

We were not able to load any forecast data for Zivo Bioscience Inc.

How can I tell whether the Zivo Bioscience Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Zivo Bioscience Inc. Over the past six months, the relative strength of its shares against the market has been 11.29%. At the current price of $0.147, shares in Zivo Bioscience Inc are trading at 18.55% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Zivo Bioscience Inc PE Ratio?

We were not able to find PE ratio data for Zivo Bioscience Inc.

Who are the key directors of Zivo Bioscience Inc?

Zivo Bioscience Inc's management team is headed by:

Philip Rice - CFO
Andrew Dahl - PRE
John Payne - IND
Christopher Maggiore - IND
Nola Masterson - IND
Robert Rondeau - IND
Who are the major shareholders of Zivo Bioscience Inc?

Here are the top five shareholders of Zivo Bioscience Inc based on the size of their shareholding:

HEP Investments, L.L.C. Corporation
Percentage owned: 25.59% (104.1m shares)
Maggiore (Christopher D) Individual Investor
Percentage owned: 14.06% (57.2m shares)
Strome Mezzanine Fund, L.P. Corporation
Percentage owned: 3.22% (13.1m shares)
Dahl (Andrew A) Individual Investor
Percentage owned: 0.17% (686k shares)
Farmers Trust Company Bank and Trust
Percentage owned: 0.07% (273k shares)
Similar to ZIVO
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.